WebThe apparent terminal half-life following oral administration is approximately 7 hours. Pharmacokinetics in Specific Populations: Geriatric Patients: Following a single 8 mg oral dose of fesoterodine, the mean (±SD) AUC and C max for the active metabolite 5-hydroxymethyl tolterodine in 12 elderly men (mean age 67 years) were 51.8 ± 26.1 … WebOct 31, 2008 · (BUSINESS WIRE)--Pfizer Inc said today that the U.S. Food and Drug Administration (FDA) approved TOVIAZ™ (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms. New once-daily TOVIAZ can significantly reduce the number of urge urinary incontinence episodes and the frequency …
Gemtesa Alternatives Compared - Drugs.com
WebKetoconazole (potent CYP3A4 inhibitors) CT. The effect of ketoconazole 200 mg twice daily for 5 days increased C max and AUC of the active metabolite of fesoterodine by 2.0- and … itraconazoleitraconazole will increase the level or effect of fesoterodine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration in patients with renal or hepa... See more imba university of south carolina
Fesoterodine - Wikipedia
WebAug 3, 2024 · Mirtazapine is extensively metabolised and eliminated via the urine and faeces within a few days. The mean half-life of elimination is 20-40 hours; longer half-lives, up to 65 hours, have occasionally been recorded and shorter half-lives have been seen in young men. The half-life of elimination is sufficient to justify once-a-day dosing. WebJan 17, 2024 · Following induction of CYP3A4 by coadministration of rifampin 600 mg once a day, Cmax and AUC of the active metabolite of fesoterodine decreased by … WebMay 15, 2009 · a single dose of 8 mg fesoterodine (Toviaz™ 8 mg) tablet manufactured at Zwickau. Drug: Fesoterodine A fesoterodine extended-release tablet (ER) ... Tmax and half-life of 5-HMT as data permit. [ Time Frame: 6 weeks ] Safety laboratory tests and adverse events [ Time Frame: 6 weeks ] imba trail rating system